
ICMJE recommendations update: what you need to know
Find out what’s new in the latest 2022 update to the ICMJE recommendations.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Find out what’s new in the latest 2022 update to the ICMJE recommendations.
Find out how authors’ self-disclosures compare with payment data reported by the medical industry.
Watch this ISMPP U webinar to find out more about the Authorship Algorithm Tool.
Recommendations from the ISMPP Authorship Task Force aim to clarify ICMJE guidelines on authorship selection criteria.
Learn about a new decision support tool developed to supplement the ICMJE criteria and GPP3 guidelines.
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
ISMPP poll result in ‘The MAP’ explores what to do if you have concerns about a potentially insufficient manuscript review by non-English speaking authors
Part B of a two-part series delves into the practicalities of patient authorship and offers tips for effective and ethical patient collaboration.
Find out more about how medical publication professionals make decisions about authorship order.
Find out more about the impact the new ICMJE disclosure form will have on authors publishing in medical journals.
We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
A new poll result published in the MAP newsletter explores the best approach for dealing with a non-responsive lead author.
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
Researchers at Nature uncover the world’s most hyperprolific authors and question our understanding of scientific authorship.
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.